25
Views
21
CrossRef citations to date
0
Altmetric
Research Article

Antioxidant α-Keto-carboxylate Pyruvate Protects Low-density Lipoprotein and Atherogenic Macrophages

, , , , , , & show all
Pages 905-914 | Published online: 07 Jul 2009
 

Abstract

Oxidative modification of low-density lipoprotein (oxLDL) plays a pathogenic role in atherogenesis. Classical antioxidants such as l -ascorbic acid can inhibit formation of oxLDL. &#102 -Keto-carboxylates such as pyruvate and congeners also display antioxidant properties in some cell-free and intact cell systems. We tested the hypothesis that pyruvate or &#102 -keto-glutarate may function as antioxidants with respect to LDL incubated with 5 or 10 &#119 M Cu 2+ alone or in combination with THP-1-derived macrophages. &#102 -Hydroxy-carboxylates ( l -lactate), linear aliphatic mono-carboxylates (acetate/caprylate) and l -ascorbic acid served as controls. The oxLDL formation was ascertained by electrophoretic mobility and oxLDL cytotoxicity was judged by macrophage viability and thiobarbituric acid reactive substances (TBARS) formation. Cu 2+ alone was not cytotoxic but increased electrophoretic mobility of cell-free LDL, stimulating TBARS. Millimolar pyruvate, &#102 -keto-glutarate, or micromolar l -ascorbic acid partially inhibited oxLDL formation, while &#102 -hydroxy-carboxylate or the aliphatic mono-carboxylates had no measurable antioxidant properties in cell-free LDL. Co-culture of LDL with macrophages and Cu 2+ augmented TBARS release and resulted in 95% macrophage death. Pyruvate improved macrophage viability with 5 &#119 M Cu 2+ up to 60%. l -Ascorbic acid ( &#83 100 &#119 M) protected macrophages up to 80%. When &#83 100 &#119 M l -ascorbic acid was combined with pyruvate, oxLDL formation and macrophage death were fully prevented. Thus, &#102 -keto-carboxylates, but not physiological &#102 -hydroxy-carboxylates or aliphatic mono-carboxylates qualify as antioxidants in LDL systems. Since &#102 -keto-carboxylates enhanced the antioxidant power of l -ascorbic acid, our findings may have implications for strategies attenuating atherosclerosis.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.